Integrin β4 promotes DNA damage-related drug resistance in triple-negative breast cancer via TNFAIP2/IQGAP1/RAC1

被引：9
|
作者：
Fang, Huan [1 ,2 ]
Ren, Wenlong [1 ,3 ]
Cui, Qiuxia [1 ,4 ,5 ]
Liang, Huichun [1 ]
Yang, Chuanyu [1 ]
Liu, Wenjing [1 ]
Wang, Xinye [1 ]
Liu, Xue [6 ]
Shi, Yujie [7 ]
Feng, Jing [6 ,8 ,9 ]
Chen, Ceshi [1 ,10 ,11 ]
机构：
[1] Chinese Acad Sci, Kunming Inst Zool, Kunming, Yunnan, Peoples R China
[2] Univ Chinese Acad Sci, Kunming Coll Life Sci, Kunming, Yunnan, Peoples R China
[3] Univ Sci & Technol China, Sch Life Sci, Hefei, Peoples R China
[4] Guangdong Med Univ, Affiliated Hosp, Zhanjiang, Guangdong, Peoples R China
[5] Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp & Shenzhen Hosp, Natl Clin Res Ctr Canc, Dept Breast Surg Oncol,Natl Canc Ctr, Shenzhen, Guangdong, Peoples R China
[6] Shanghai Univ Med & Hlth Sci, Affiliated Peoples Hosp 6, South Campus, Shanghai 201499, Peoples R China
[7] Zhengzhou Univ, Henan Prov Peoples Hosp, Dept Pathol, Zhengzhou, Peoples R China
[8] Chinese Univ Hong Kong, Affiliated Hosp 2, Shenzhen, Peoples R China
[9] Southern Med Univ, Sch Lab Med & Biotechnol, Guangzhou, Guangdong, Peoples R China
[10] Kunming Med Univ, Acad Biomed Engn, Kunming, Peoples R China
[11] Kunming Med Univ, Affiliated Hosp 3, Kunming, Peoples R China
来源：
ELIFE | 2023年 / 12卷
基金：
国家重点研发计划; 中国国家自然科学基金;
关键词：
ITGB4; TNFAIP2; IQGAP1; RAC1; drug resistance; triple-negative breast cancer; Human; RAC; ACTIVATION; METASTASIS; CARCINOMA; PROTEINS; TNFAIP2; IQGAP1; GENE; AKT;
D O I：
10.7554/eLife.88483
中图分类号：
Q [生物科学];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
Anti-tumor drug resistance is a challenge for human triple-negative breast cancer (TNBC) treatment. Our previous work demonstrated that TNFAIP2 activates RAC1 to promote TNBC cell proliferation and migration. However, the mechanism by which TNFAIP2 activates RAC1 is unknown. In this study, we found that TNFAIP2 interacts with IQGAP1 and Integrin beta 4. Integrin beta 4 activates RAC1 through TNFAIP2 and IQGAP1 and confers DNA damage-related drug resistance in TNBC. These results indicate that the Integrin beta 4/TNFAIP2/IQGAP1/RAC1 axis provides potential therapeutic targets to overcome DNA damage-related drug resistance in TNBC.
引用
收藏
页数：21
相关论文
共 50 条
  • [41] BUB1 interferes with the repair of radiation-induced DNA damage to radiosensitize triple-negative breast cancer
    Sriramulu, Sushmitha
    Thoidingjam, Shivani
    Li, Pin
    Brown, Stephen L.
    Siddiqui, Farzan
    Movsas, Benjamin
    Green, Michael
    Speers, Corey
    Nyati, Shyam
    CANCER RESEARCH, 2024, 84 (06)
  • [42] LIMK2 promotes the metastatic progression of triple-negative breast cancer by activating SRPK1
    Malvi, Parmanand
    Janostiak, Radoslav
    Chava, Suresh
    Manrai, Padmini
    Yoon, Esther
    Singh, Kamaljeet
    Harigopal, Malini
    Gupta, Romi
    Wajapeyee, Narendra
    ONCOGENESIS, 2020, 9 (08)
  • [43] RIPK1-dependent necroptosis promotes vasculogenic mimicry formation via eIF4E in triple-negative breast cancer
    Li, Fan
    Sun, Huizhi
    Yu, Yihui
    Che, Na
    Han, Jiyuan
    Cheng, Runfen
    Zhao, Nan
    Guo, Yuhong
    Huang, Chongbiao
    Zhang, Danfang
    CELL DEATH & DISEASE, 2023, 14 (05)
  • [44] RIPK1-dependent necroptosis promotes vasculogenic mimicry formation via eIF4E in triple-negative breast cancer
    Fan Li
    Huizhi Sun
    Yihui Yu
    Na Che
    Jiyuan Han
    Runfen Cheng
    Nan Zhao
    Yuhong Guo
    Chongbiao Huang
    Danfang Zhang
    Cell Death & Disease, 14
  • [45] Role of eIF4A1 in triple-negative breast cancer stem-likecell-mediateddrug resistance
    Raman, Dayanidhi
    Tiwari, Amit K.
    CANCER REPORTS, 2022, 5 (12)
  • [46] MUC1-C Dictates PBRM1-Mediated Chronic Induction of Interferon Signaling, DNA Damage Resistance, and Immunosuppression in Triple-Negative Breast Cancer
    Yamashita, Nami
    Morimoto, Yoshihiro
    Fushimi, Atsushi
    Ahmad, Rehan
    Bhattacharya, Atrayee
    Daimon, Tatsuaki
    Haratake, Naoki
    Inoue, Yuka
    Ishikawa, Satoshi
    Yamamoto, Masaaki
    Hata, Tsuyoshi
    Akiyoshi, Sayuri
    Hu, Qiang
    Liu, Tao
    Withers, Henry
    Liu, Song
    Shapiro, Geoffrey I.
    Yoshizumi, Tomoharu
    Long, Mark D.
    Kufe, Donald
    MOLECULAR CANCER RESEARCH, 2023, 21 (03) : 274 - 289
  • [47] MCT4/Lactate Promotes PD-L1 Glycosylation in Triple-Negative Breast Cancer Cells
    Duan, Xianxian
    Xie, Yu
    Yu, Jing
    Hu, Xiao
    Liu, Zhanzhao
    Li, Ning
    Qin, Junfang
    Lan, Lan
    Yuan, Mengci
    Pan, Zhanyu
    Wang, Yue
    JOURNAL OF ONCOLOGY, 2022, 2022
  • [48] PKMYT1 knockdown inhibits cholesterol biosynthesis and promotes the drug sensitivity of triple-negative breast cancer cells to atorvastatin
    Gao, Wei
    Guo, Xin
    Sun, Linlin
    Gai, Jinwei
    Cao, Yinan
    Zhang, Shuqun
    PEERJ, 2024, 12
  • [49] Serum Amyloid A1 Mediates Paclitaxel Resistance via MD2-Dependent Pathways in Triple-Negative Breast Cancer
    Chen, Kangmin
    Zhao, Yanni
    Jin, Tianyang
    Xu, Tingxin
    Zhu, Conglun
    Shen, Hui
    Xu, Xiaohong
    Jiang, Yongsheng
    Wang, Yi
    Xue, Shihang
    DRUG DEVELOPMENT RESEARCH, 2025, 86 (02)
  • [50] ELP-dependent expression of MCL1 promotes resistance to EGFR inhibition in triple-negative breast cancer cells
    Cruz-Gordillo, Peter
    Honeywell, Megan E.
    Harper, Nicholas W.
    Leete, Thomas
    Lee, Michael J.
    SCIENCE SIGNALING, 2020, 13 (658)
12345